DEC2 Activators
The chemical class of DEC2 activators encompasses compounds that influence DEC2, a crucial player in circadian rhythm regulation. These activators operate through diverse molecular mechanisms, highlighting the intricate interplay between cellular signaling pathways and the modulation of DEC2 activity. One prominent subgroup within DEC2 activators includes compounds like resveratrol, AICAR, and metformin, which directly engage the SIRT1/AMPK pathway. Resveratrol, a polyphenolic compound found in red grapes, activates DEC2 through SIRT1-mediated deacetylation and subsequent AMPK phosphorylation. Similarly, AICAR and metformin, both AMPK activators, promote DEC2 phosphorylation, emphasizing the significance of the AMPK pathway in DEC2 regulation. This direct interaction places DEC2 at the nexus of cellular energy sensing and circadian rhythm coordination.
Another subgroup, represented by dorsomorphin and lithium chloride, focuses on GSK-3β inhibition. Dorsomorphin, an AMPK inhibitor, indirectly activates DEC2 by relieving AMPK-mediated inhibition and preventing phosphorylation. Lithium chloride, on the other hand, stabilizes DEC2 by inhibiting GSK-3β, showcasing the intricate balance between kinase activity and DEC2 degradation. This subgroup underscores the importance of GSK-3β-mediated regulation in shaping DEC2's role in circadian rhythms. Additionally, compounds like 6-Bromoindirubin-3'-oxime and SB216763 highlight the modulation of DEC2 through GSK-3β inhibition, offering insights into the stability and transcriptional activity of DEC2. These findings reveal potential pharmacological strategies for enhancing DEC2 function and stability, providing avenues for future research into circadian rhythm disorders. The chemical class of DEC2 activators, characterized by its diverse mechanisms of action, unveils the complexity of DEC2 regulation and its integration into cellular signaling networks. Understanding these activators broadens our perspective on the molecular underpinnings of circadian rhythms and opens new avenues for targeted interventions in circadian-related pathologies.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol, a polyphenolic compound found in red grapes, activates DEC2 by modulating the SIRT1/AMPK pathway. Resveratrol activates SIRT1, leading to deacetylation of DEC2 and subsequent activation by AMPK. This direct interaction enhances DEC2's role in circadian rhythm regulation. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR, an AMP analog, activates DEC2 by promoting AMPK phosphorylation. AICAR increases cellular AMP levels, activating AMPK, which in turn phosphorylates DEC2, enhancing its transcriptional activity. This activation is linked to energy stress response pathways, implicating DEC2 in cellular adaptation to metabolic fluctuations. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
2-Deoxyglucose activates DEC2 by inducing cellular stress through inhibition of glycolysis. This metabolic perturbation activates AMPK, leading to the phosphorylation and activation of DEC2. The connection between energy stress and DEC2 highlights its role in coordinating circadian rhythms with cellular energy status. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin activates DEC2 by modulating the AMPK pathway. As an AMPK activator, metformin enhances DEC2 activity by promoting its phosphorylation. The interplay between metformin, AMPK, and DEC2 suggests a potential link between DEC2 and metabolic pathways in the regulation of circadian rhythms. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
A769662, an AMPK activator, directly activates DEC2 by promoting its phosphorylation. By mimicking AMP, A769662 activates AMPK, which phosphorylates and activates DEC2. This pharmacological activation sheds light on the potential pharmacological modulation of DEC2 for circadian rhythm regulation. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $92.00 | 1 | |
Berberine activates DEC2 by modulating the AMPK pathway. By activating AMPK, berberine promotes DEC2 phosphorylation, enhancing its transcriptional activity. The connection between berberine, AMPK, and DEC2 suggests a potential avenue for natural product-based modulation of circadian rhythms. | ||||||
Dorsomorphin dihydrochloride | 1219168-18-9 | sc-361173 sc-361173A | 10 mg 50 mg | $186.00 $751.00 | 28 | |
Dorsomorphin, an AMPK inhibitor, indirectly activates DEC2 by relieving AMPK-mediated inhibition. By inhibiting AMPK, dorsomorphin prevents DEC2 phosphorylation, leading to increased transcriptional activity. This pharmacological approach highlights the intricate regulation of DEC2 through AMPK signaling in circadian rhythm modulation. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $58.00 $188.00 $884.00 | 10 | |
GSK-3 Inhibitor IX activates DEC2 by inhibiting GSK-3β. GSK-3β inhibition results in enhanced DEC2 stability and transcriptional activity. This interaction provides insight into the regulation of DEC2 by signaling pathways involving GSK-3β, adding a layer of complexity to its role in circadian rhythm regulation. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride activates DEC2 by inhibiting GSK-3β. By suppressing GSK-3β activity, lithium chloride stabilizes DEC2 and enhances its transcriptional activity. This pharmacological modulation reveals a potential link between DEC2 and the GSK-3β signaling pathway in the regulation of circadian rhythms. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine activates DEC2 through epigenetic modulation. By inhibiting DNA methylation, 5-azacytidine promotes DEC2 expression, leading to increased protein levels and transcriptional activity. This epigenetic activation provides a unique avenue for the regulation of DEC2 expression and function in circadian rhythm control. | ||||||